For decades, advocates of psychedelic substances have brought a bold message to Washington, D.C., that currently illicit, mind-altering drugs, such as LSD and MDMA, should warrant approval for therapeutic use in treating severe depression, PTSD, and other treatment-resistant conditions.

White House press secretary Karoline Leavitt has revealed that President Donald Trump has been diagnosed with chronic venous insufficiency, a blood circulation issue.